BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/12/2017 5:24:00 PM | Browse: 877 | Download: 1128
 |
Received |
|
2016-10-21 09:55 |
|
Peer-Review Started |
|
2016-10-24 08:22 |
|
To Make the First Decision |
|
2016-12-19 11:29 |
|
Return for Revision |
|
2016-12-20 10:58 |
|
Revised |
|
2016-12-30 14:36 |
|
Second Decision |
|
2017-01-16 13:58 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2017-01-17 16:59 |
|
Articles in Press |
|
2017-01-17 16:59 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2017-02-07 22:03 |
|
Publish the Manuscript Online |
|
2017-02-12 17:23 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Prospective Study |
| Article Title |
Modified docetaxel, cisplatin and capecitabine for stage Ⅳ gastric cancer in Japanese patients: A feasibility study
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Osamu Maeda, Ayumu Matsuoka, Ryoji Miyahara, Kohei Funasaka, Yoshiki Hirooka, Masahide Fukaya, Masato Nagino, Yasuhiro Kodera, Hidemi Goto and Yuichi Ando |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Osamu Maeda, MD, PhD, Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8560, Aichi, Japan. maeda-o@med.nagoya-u.ac.jp |
| Key Words |
Docetaxel; Cisplatin; Capecitabine; Gastric cancer |
| Core Tip |
A combination of fluoropyrimidine and platinum is a standard treatment for unresectable gastric cancer. Although the addition of a taxane to this doublet is expected to improve effectiveness, research has demonstrated that such triplet regimens often cause adverse effects, including neutropenia. To reduce adverse events but maintain therapeutic effectiveness, we devised a triplet regimen with modified dosages. Modified docetaxel, cisplatin and capecitabine treatment was safe and effective for stage Ⅳ gastric cancer. Three of the eight treated patients underwent conversion surgery and achieved long-term survival without recurrence. |
| Publish Date |
2017-02-12 17:23 |
| Citation |
Maeda O, Matsuoka A, Miyahara R, Funasaka K, Hirooka Y, Fukaya M, Nagino M, Kodera Y, Goto H, Ando Y. Modified docetaxel, cisplatin and capecitabine for stage Ⅳ gastric cancer in Japanese patients: A feasibility study. World J Gastroenterol 2017; 23(6): 1090-1097 |
| URL |
http://www.wjgnet.com/1007-9327/full/v23/i6/1090.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v23.i6.1090 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
